{"title":"Precision nutrition: An objective approach in metabolic disorder.","authors":"Ravi Kant, Poonam Yadav, Shruti Barnwal","doi":"10.22088/cjim.17.3.534","DOIUrl":"https://doi.org/10.22088/cjim.17.3.534","url":null,"abstract":"<p><p>Precision nutrition and personalized nutrition, deliver more preventive and practical dietary advice. Precision nutrition comprises dietary habits, food behavior, physical activity, deep phenotyping, metabolomics, microbiota, and nutrigenomics. Precision nutrition includes several clinical practice approaches, such as genetics, dietary habits, food behavior, physical activity, microbiota, and metabolome. With an overwhelming increase in obesity and associated metabolic disturbances, such as type 2 diabetes and cardiovascular diseases, precision nutrition represents a promising approach for preventing and managing metabolic syndrome. This review article highlights the concept of precision nutrition in clinical practice, especially in type 2 diabetes mellitus and metabolic disorders, to prevent and manage the disease. Precision nutrition is an emerging specialty of nutrition that produces a promising approach in clinical practice.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"17 3","pages":"534-543"},"PeriodicalIF":1.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13689548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Innovative approaches: Utilizing artificial intelligence for early diagnosis of main neurodegenerative diseases.","authors":"Hadi Ebrahimi, Ebrahim Hejazian, Zohre Eftekhari","doi":"10.22088/cjim.17.3.517","DOIUrl":"https://doi.org/10.22088/cjim.17.3.517","url":null,"abstract":"<p><strong>Background: </strong>By incorporating advanced signal processing and artificial intelligence (AI)/machine learning techniques (MLT) in an automated manner, this system can be trained using extensive patient data, physiological signals, and images. Using state-of-the-art AI models and high-quality clinical data has shown promise in improving prognostic and diagnostic models for neurological diseases. However, it is essential to recognize that AI, machine, and deep-learning algorithms are not universally applicable solutions for all clinical data and inquiries.</p><p><strong>Methods: </strong>This paper offers a comprehensive review of cutting-edge research on the automated diagnosis of major neurological disorders, with a primary focus on the application of AI techniques. An extensive search was conducted in the PubMed and Scopus databases from September 2023 to January 2025; 220 articles were retrieved from the initial search. After eliminating duplicate entries, a total of 105 distinct articles remained. Subsequently, in March 2025, 4 more articles directly pertinent to the topic of interest were identified and included.</p><p><strong>Results: </strong>AI methodologies, particularly Support Vector Machines (SVM) and XGBoost, have demonstrated considerable potential in improving the efficacy of screening tests. AI methods enhance neurological disease diagnosis by integrating advanced diffusion MRI techniques and next-generation PET tracers. Deep learning models, such as convolutional neural networks, improve diagnostic precision and facilitate early detection of neurodegeneration and inflammation in various disorders.</p><p><strong>Conclusions: </strong>Artificial intelligence in combination with conventional methods serves as a valuable resource for the early, precise, and non-invasive identification of neurodegenerative disorders. Additionally, it aids in evaluating treatment efficacy and forecasting the progression of these diseases.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"17 3","pages":"517-533"},"PeriodicalIF":1.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13688886/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammad Hosseinzadeh, Mohammad Milad Shirvandehi, Navid Sehat, Azam Moslemi, Ehsanollah Ghaznavi-Rad, Behzad Khansarinejad, Hosein Sarmadian, Mohammad Rezvanfar, Farideh Jalali Mashayekhi
{"title":"Hormonal dysregulation in COVID-19: A comparative analysis of cortisol, growth hormone, and IGF-1 levels across different severities of illness.","authors":"Mohammad Hosseinzadeh, Mohammad Milad Shirvandehi, Navid Sehat, Azam Moslemi, Ehsanollah Ghaznavi-Rad, Behzad Khansarinejad, Hosein Sarmadian, Mohammad Rezvanfar, Farideh Jalali Mashayekhi","doi":"10.22088/cjim.17.3.671","DOIUrl":"https://doi.org/10.22088/cjim.17.3.671","url":null,"abstract":"<p><strong>Background: </strong>COVID-19 has multiple effects on the endocrine system, particularly altering the levels of growth hormone (GH), insulin-like growth factor-1 (IGF-1), and cortisol, which may influence disease severity and prognosis. This study aimed to evaluate circulating levels of GH, IGF-1, and cortisol in COVID-19 patients categorized by disease severity, including outpatients, inpatients, and intensive care unit (ICU) patients.</p><p><strong>Methods: </strong>A total of 118 confirmed COVID-19 patients were divided into three groups: outpatients, inpatients, and ICU patients. Serum levels of GH, IGF-1, and cortisol were measured using ELISA and statistically compared across groups. Correlations among these hormones were also analyzed.</p><p><strong>Results: </strong>Cortisol levels were highest in inpatients, intermediate in ICU patients, and lowest in outpatients. GH levels were reduced in ICU patients compared to other groups, with no difference between inpatients and outpatients. IGF-1 levels were highest in outpatients, followed by inpatients, and lowest in ICU patients. A significant inverse correlation between cortisol and IGF-1 was observed only in ICU patients (p = 0.013).</p><p><strong>Conclusion: </strong>COVID-19 severity is associated with dysregulation of GH, IGF-1, and cortisol. The inverse cortisol-IGF-1 correlation in ICU patients suggests the impact of physiological stress on hormonal imbalance and impaired recovery. Endocrine interventions may improve clinical outcomes in severe cases.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"17 3","pages":"671-677"},"PeriodicalIF":1.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13690140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Levosimendan in Trastuzumab-induced cardiotoxicity: A mechanism-based perspective.","authors":"Zahra Nazari Taloki","doi":"10.22088/cjim.17.3.688","DOIUrl":"https://doi.org/10.22088/cjim.17.3.688","url":null,"abstract":"","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"17 3","pages":"688-689"},"PeriodicalIF":1.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13690172/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Global prevalence of recurrent aphthous stomatitis among school and university students: a systematic review and meta-analysis.","authors":"Ariana Rezaei Majd, Hossein-Ali Nikbakht, Pouyan Ebrahimi, Amin Esmaeilnia Shirvani, Simin Mouodi","doi":"10.22088/cjim.17.3.480","DOIUrl":"https://doi.org/10.22088/cjim.17.3.480","url":null,"abstract":"<p><strong>Background: </strong>Aphthous lesions are common oral diseases that can affect the quality of life, especially in students, and are frequently triggered by factors such as stress. This study aimed to assess the global prevalence of recurrent aphthous stomatitis (RAS) among students.</p><p><strong>Methods: </strong><i>Methods</i> <i>:</i> This systematic review analyzed relevant evidence from international databases, including Scopus, PubMed/Medline, Web of Science, Embase, and Google Scholar, covering data from the earliest available records up to February 2025. Heterogeneity was assessed using Cochran's Q test and the I² statistic. Subgroup analyses were conducted based on gender, measurement tools, and target population, while meta-regression analysis was performed considering the study year.</p><p><strong>Results: </strong><i>Results</i> <i>:</i> A total of 614 studies were reviewed, of which 28 met the inclusion criteria. Based on the random-effects model, the overall prevalence of RAS among the target population of students (both school and university students) was estimated to be 0.14 (95% CI, 0.06-0.24). The prevalence among school students was 0.12 (95% CI, 0.02-0.28), while among university students it was 0.15 (95% CI, 0.05-0.29). Furthermore, the prevalence of RAS was reported as 0.18 (95% CI, 0.05-0.36) in females and 0.10 (95% CI, 0.04-0.19) in males. Although the prevalence appeared to decrease over time, this reduction was not statistically significant (Reg Coef = -0.13, p = 0.115).</p><p><strong>Conclusions: </strong>This study estimates the global prevalence of RAS among students to be 14%. The findings highlight the need for standardized strategies for the diagnosis and management of oral aphthous lesions in schools and universities.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"17 3","pages":"480-493"},"PeriodicalIF":1.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13689519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maja Avramovska, Zorica Nikleski, Petar Avramovski, Liljana Todorovska, Stefan Talev, Svetlana Stefanovska, Kosta Sotiroski, Dejan Zdraveski
{"title":"Pulse wave velocity as a non-invasive discriminative marker of bone health in postmenopausal women.","authors":"Maja Avramovska, Zorica Nikleski, Petar Avramovski, Liljana Todorovska, Stefan Talev, Svetlana Stefanovska, Kosta Sotiroski, Dejan Zdraveski","doi":"10.22088/cjim.17.3.622","DOIUrl":"https://doi.org/10.22088/cjim.17.3.622","url":null,"abstract":"<p><strong>Background: </strong>Increased arterial stiffness has been linked to osteoporosis. This study evaluates Pulse Wave Velocity (PWV) as a discriminator of osteopenia and osteoporosis at the lumbar spine and femoral neck in postmenopausal women.</p><p><strong>Methods: </strong>In this cross-sectional study, arterial stiffness and bone mineral density (BMD) at the spine and femoral neck were assessed using carotid-to-femoral Pulse PWV and dual-energy x-ray absorptiometry (DXA). Eighteen premenopausal women (mean age 41.30±4.30 years) and forty-eight postmenopausal women (mean age 59.40±9.10 years) participated in the study. Osteoporosis (T-score ≤-2.5) and osteopenia (-2.5< T-score ≤-1) were defined by T-score criteria.</p><p><strong>Results: </strong>Pearson's correlation results showed: PWV and femoral neck BMD (r = -0.439, P = 0.002), PWV and spine BMD (r =-0.358, P = 0.012), and PWV and menopausal duration (r = 0.381, P = 0.008). PWV demonstrated significant discriminative ability for femoral neck osteopenia [b = 0.6472, Wald = 5.717, Odds ratio (OR) = 1.910, P = 0.017, Area Under Curve (AUC) = 0.704], femoral neck osteoporosis (b = 0.7206, Wald = 5.838, OR = 2.056, P = 0.016, AUC = 0.758), spine osteopenia (b = 0.8489, Wald = 5.639, OR = 2.337, P = 0.018, AUC = 0.677), and spine osteoporosis (b = 1.0829, Wald = 8.269, OR = 2.953, P = 0.004, AUC = 0.804).</p><p><strong>Conclusion: </strong>PWV was inversely correlated with femoral neck and spine BMD, and positively correlated with menopausal duration. It serves as a significant discriminator of bone health, indicating increased odds of osteopenia and osteoporosis.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"17 3","pages":"622-632"},"PeriodicalIF":1.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13690173/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shadi Bahrami, Neda Ramezani, Mohammad Yazdan Panah, Saeed Vaheb, Omid Mirmosayyeb, Fariba Davanian, Sahand Golparvar, Iman Adibi, Vahid Shaygannejad
{"title":"Thalamic atrophy in active and inactive secondary progressive multiple sclerosis patients: A comparative study.","authors":"Shadi Bahrami, Neda Ramezani, Mohammad Yazdan Panah, Saeed Vaheb, Omid Mirmosayyeb, Fariba Davanian, Sahand Golparvar, Iman Adibi, Vahid Shaygannejad","doi":"10.22088/cjim.17.3.595","DOIUrl":"10.22088/cjim.17.3.595","url":null,"abstract":"<p><strong>Background: </strong>Thalamic atrophy may be an indicator of neurodegeneration in people with secondary progressive multiple sclerosis (pwSPMS). The atrophy usually begins asymmetrically, and the thalamic asymmetry index (TAI) can be used to estimate the severity of neurodegeneration. SPMS is commonly divided into two groups of active and inactive. No study has compared TAI between SPMS groups and examine its relationships with cognitive and motor measures in pwSPMS. This study aimed to compare the TAI between active and inactive pwSPMS and to examine its relationship with key clinical, cognitive, and motor variables.</p><p><strong>Methods: </strong>In this cross-sectional study, 38 pwSPMS (15 active and 23 inactive) were enrolled from February to November 2024. MRI-based volumetric measurements were used to determine thalamic volumes and calculate the TAI. Cognitive and motor tests, including the SDMT, PASAT, and 9HPT were also administered alongside clinical examinations.</p><p><strong>Results: </strong>Active SPMS patients had significantly lower NTV compared to inactive patients (Cohen's d = -1.58, p < 0.001). No significant difference in TAI was observed between groups. NTV correlated with cognitive scores in both active (r = 0.74, P = 0.002) and inactive (r = 0.65, p < 0.001) groups and with disability in the inactive group (r = -0.5, P= 0.014). Active SPMS patients showed worse cognitive and motor performance.</p><p><strong>Conclusion: </strong>Thalamic atrophy is more severe in active SPMS and is associated with worse cognitive and motor outcomes. While thalamic asymmetry did not differentiate between subgroups, it may serve as a marker for functional status in SPMS.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"17 3","pages":"595-602"},"PeriodicalIF":1.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13719435/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149295019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Depressive symptoms and related factors in adults with heart failure: A multicenter cross-sectional study in northern Iran (2022-2023).","authors":"Romina Hamzehpour, Naghmeh Zieaie Amiri, Milad Ghanbarzadeh, Angela Hamidia, Sakine Javadian Kotnaei, Mahboobeh Khoozan, Hoda Shirafkan, Mahasti Emami Hamzehkolaee","doi":"10.22088/cjim.17.3.603","DOIUrl":"https://doi.org/10.22088/cjim.17.3.603","url":null,"abstract":"<p><strong>Background: </strong>Depressive symptoms are frequent in patients with heart failure (HF), but estimates vary across settings. Clarifying their burden and related factors can inform integrated care. This study aimed to estimate the prevalence of depressive symptoms in adults with HF and identify associated factors.</p><p><strong>Methods: </strong>We conducted a multicenter cross-sectional study (June 2022-February 2023) in cardiology wards and outpatient clinics of three hospitals affiliated with Babol University of Medical Sciences, northern Iran. Consecutive adults (≥18 years) with cardiologist-confirmed HF completed the 17-item Hamilton Depression Rating Scale (HAM-D-17); a score >7 was considered indicative of clinically relevant depressive symptoms. Baseline demographic and clinical characteristics were recorded. Independent correlates of depressive symptoms were examined using multivariable logistic regression.</p><p><strong>Results: </strong>Of 250 participants (mean age 60.3±15.1 years; 46.4% women), 51 (20.4%) had depressive symptoms (HAM-D-17 >7): mild 18.4%, moderate 1.6%, severe 0.4%. In unadjusted analyses, depressive symptoms were more common in women, in unemployed and unmarried participants, and in those with more advanced New York Heart Association (NYHA) functional class. In multivariable models, female sex (OR 6.57, 95% CI 2.91-14.85) and higher NYHA class were associated with depressive symptoms (p<0.01), whereas left ventricular ejection fraction and HF etiology were not.</p><p><strong>Conclusion: </strong>Approximately one fifth of adults with HF had clinically relevant depressive symptoms, particularly women and patients with worse functional status. Routine screening and integrated psychosocial care should be incorporated into HF management, with special attention to patients in advanced NYHA classes.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"17 3","pages":"603-612"},"PeriodicalIF":1.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13690160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammad Moslemi, Marjan Mouodi, Seyed Reza Hosseini, Reza Ghadimi, Nasim Hosseinzadeh, Ali Bijani
{"title":"Relationship between visceral fat and diabetes mellitus in the elderly: A cross-sectional study.","authors":"Mohammad Moslemi, Marjan Mouodi, Seyed Reza Hosseini, Reza Ghadimi, Nasim Hosseinzadeh, Ali Bijani","doi":"10.22088/cjim.17.3.659","DOIUrl":"https://doi.org/10.22088/cjim.17.3.659","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus and obesity are major public health concerns in older adults, and visceral adipose tissue (VAT) is suggested to play a critical role in the metabolic dysfunction observed in type 2 diabetes. This cross-sectional study investigated the relationship between VAT and other obesity-related indicators with type 2 diabetes mellitus in elderly adults in northern Iran.</p><p><strong>Methods: </strong>Participants aged 60 years and older were included, comprising 300 individuals with diabetes and 600 controls for comparative analysis, matched by age and sex. Demographic characteristics, physical activity, anthropometric measures, fasting blood sugar (FBS), and lipid profile were assessed. VAT and other body fat parameters were measured using dual-energy x-ray absorptiometry (DXA). Statistical analyses including t-tests, Pearson correlation, and ROC curve analysis were performed.</p><p><strong>Results: </strong>The diabetic group had a significantly higher VAT mass (954.54±319.82 vs. 831.95±323.20, p <0.001) and volume (1031.92±345.79 vs. 899.38±349.43, p <0.001) than controls, while total body fat mass and percentage were not significantly different in between groups (p = 0.052, 0.878; respectively). FBS showed positive correlation with VAT metrics (r = 0.127, p < 0.001). VAT mass and volume yielded the highest AUCs (0.605, 95% CI: 0.567-0.644, p < 0.001) for diabetes discrimination.</p><p><strong>Conclusion: </strong>Our findings support the significant association of VAT and diabetes in older adults, in contrast to general fat measures. However, discriminatory power of VAT remained poor to inconclusive in our study, especially in older women. Further analysis is needed to clarify the clinical utility of VAT in screening and prevention.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"17 3","pages":"659-670"},"PeriodicalIF":1.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13690163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}